½ÃÀ庸°í¼­
»óǰÄÚµå
1788506

¼¼°èÀÇ »ý¸í°úÇÐ ½Ã¾à ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2035³â)

Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 178 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

»ý¸í°úÇÐ ½Ã¾à ½ÃÀå - ºÐ¼® ¹üÀ§

TMRÀÇ Á¶»ç º¸°í¼­ "¼¼°èÀÇ »ý¸í°úÇÐ ½Ã¾à ½ÃÀå"Àº 2025-2035³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ¾ò±â À§ÇØ °ú°Å¿Í ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ Á¶»çÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2025³âÀ» ±âÁØ ¿¬µµ, 2035³âÀ» ¿¹Ãø ¿¬µµ·Î ÇÏ¿© 2025³âºÎÅÍ 2035³â±îÁö ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀåÀÇ ¸ÅÃâ°ú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, 2025-2035³â±îÁöÀÇ ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀåÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)µµ Á¦½ÃµÇ¾î ÀÖ½À´Ï´Ù.

º» º¸°í¼­´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ ÅëÇØ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­ ¾Ö³Î¸®½ºÆ®´Â KOL(Key Opinion Leader), ¾÷°è ¸®´õ, ¿ÀÇǴϾð Á¦Á¶¾÷ü¸¦ ´ë»óÀ¸·Î ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. 2Â÷ Á¶»ç¿¡¼­´Â ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµÀÚ·á, °ü·Ã ¹®¼­ µîÀ» ÂüÁ¶ÇÏ¿© »ý¸í°úÇÐ ½Ã¾à ½ÃÀåÀ» Ãß·ÐÇß½À´Ï´Ù.

½ÃÀå ÇöȲ
½ÃÀå ±Ô¸ð(2024³â) 623¾ï ´Þ·¯
½ÃÀå ±Ô¸ð(2035³â) 1,134¾ï ´Þ·¯
CAGR 5.7%

ÀÌ º¸°í¼­´Â ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå °æÀï ±¸µµ¸¦ Á¶»çÇß½À´Ï´Ù. ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ È®ÀεǾúÀ¸¸ç, °¢ ±â¾÷µéÀº ´Ù¾çÇÑ ¼Ó¼ºº°·Î ÇÁ·ÎÆÄÀϸµµÇ¾ú½À´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óÅÂ, ÃÖ±Ù µ¿Çâ, SWOT´Â º» º¸°í¼­¿¡¼­ ¼Ò°³ÇÑ ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀåÀÇ ±â¾÷ ¼Ó¼ºÀÔ´Ï´Ù.

¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå º¸°í¼­°¡ ´äº¯ÇÑ ÁÖ¿ä Áú¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

  • ¿¹Ãø ±â°£ µ¿¾È ¸ðµç Áö¿ª¿¡¼­ ¾ÆÆç·¹½Ã½ºÀÇ ¸ÅÃâ/¼öÀÍÀº?
  • ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå¿¡¼­ÀÇ ºñÁî´Ï½º ±âȸ´Â?
  • ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, ±âȸ, À§Çù ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ Áö¿ª ½ÃÀåÀº ¾îµðÀΰ¡?
  • 2035³â ¼¼°è¿¡¼­ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â?
  • ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÎ¹®Àº?
  • ¼¼°è ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â °¢ ±â¾÷ ½ÃÀå ÁöÀ§´Â?

»ý¸í°úÇÐ ½Ã¾à ½ÃÀå - Á¶»ç ¸ñÀû ¹× Á¶»ç ¹æ¹ý

¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­´Â °³¿ä·Î ½ÃÀÛÇÏ¿© ¿¬±¸ ¹üÀ§¿Í ¸ñÀûÀ» ¼³¸íÇÕ´Ï´Ù. º» Á¶»çÀÇ ¸ñÀû, ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä º¥´õ¿Í À¯Åë¾÷ü, Á¦Ç° ½ÂÀο¡ °üÇÑ ±ÔÁ¦ ½Ã³ª¸®¿À¿¡ ´ëÇØ »ó¼¼ÇÏ°Ô ¼³¸íÇÕ´Ï´Ù.

º» º¸°í¼­´Â °¡µ¶¼ºÀ» °í·ÁÇÏ¿© °¢ ¼½¼ÇÀ» À庰·Î ³ª´©¾î ·¹À̾ƿôÀ» ±¸¼ºÇÏ¿´½À´Ï´Ù. º» º¸°í¼­´Â ±×·¡ÇÁ¿Í Ç¥¸¦ ÀûÀýÈ÷ ¹èÄ¡ÇÑ Á¾ÇÕÀûÀÎ ÀÚ·á·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÁÖ¿ä ºÎ¹®ÀÇ ºÐ¼®°ú ¿¹ÃøÄ¡¸¦ µµ½ÄÈ­ÇÏ¿© µ¶ÀÚ¿¡°Ô ½Ã°¢ÀûÀ¸·Î ¾îÇÊÇÕ´Ï´Ù. ¶ÇÇÑ, °ú°Å¿Í ¿¹Ãø ±â°£ ¸»ÀÇ ÁÖ¿ä ºÎ¹®º° ½ÃÀå Á¡À¯À²À» ºñ±³ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀåÀ» Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°·Î ºÐ¼®ÇÕ´Ï´Ù. °¢ ±âÁØÀÇ ÁÖ¿ä ºÎ¹®À» »ó¼¼ÇÏ°Ô Á¶»çÇϰí, 2035³â ¸» ±âÁØ °¢ ºÎ¹® ½ÃÀå Á¡À¯À²À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ÅëÇØ ½ÃÀå ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è »ý¸í°úÇÐ ½Ã¾à ½ÃÀå ÅõÀÚ¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ºñÁî´Ï½º ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°èÀÇ »ý¸í°úÇÐ ½Ã¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø(2020-2035³â)

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • »ý¸í°úÇÐ ½Ã¾à¿¡ °ü·ÃµÈ ±â¼ú Áøº¸
  • ÁÖ¿ä Áö¿ª/±¹°¡ ±ÔÁ¦ »óȲ
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ÁÖ¿ä Á¦Ç°/ºê·£µå ºÐ¼®
  • ÁÖ¿ä ¾÷°è À̺¥Æ®
  • ÁÖ¿ä Á¦Ç° Á¦Á¶¾÷ü¿¡ ±Ù°ÅÇÑ ±â´É ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °æÀïÀÌ Á¦°øÇÏ´Â Á¦Ç° º¥Ä¡¸¶Å·

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° À¯Çüº°

  • ¼­·Ð ¹× Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/ÁøÀü
  • ½ÃÀå ¿¹Ãø(±Ý¾× ±âÁØ) : Á¦Ç° À¯Çüº°(2020-2035³â)
    • ¿ÏÃæ¾× ¹× ¿ë¾×
    • Å©·Î¸¶Åä±×·¡ÇÇ ½Ã¾à
    • ºÐÀÚÁø´Ü ½Ã¾à
    • ¸é¿ªÃøÁ¤ ½Ã¾à
    • ÀÓ»óÈ­ÇÐ ½Ã¾à
    • Ç÷οì Äɹ̽ºÆ®¸® ½Ã¾à
    • ¼¼Æ÷ ¹× Á¶Á÷¹è¾ç ½Ã¾à
    • Ç÷¾×ÇÐ ¹× Ç÷¾× ÀÀ°í ½Ã¾à
    • ¹Ì»ý¹°ÇÐ ½Ã¾à
    • Àü±â¿µµ¿ ½Ã¾à
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â : Á¦Ç° À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°

  • ¼­·Ð ¹× Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/ÁøÀü
  • ½ÃÀå ¿¹Ãø(±Ý¾× ±âÁØ) : ¿ëµµº°(2020-2035³â)
    • ÀÓ»ó Áø´Ü
    • Drug Discovery
    • À¯ÀüÀÚ °øÇÐ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â : ¿ëµµº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð ¹× Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/ÁøÀü
  • ½ÃÀå ¿¹Ãø(±Ý¾× ±âÁØ) : ÃÖÁ¾»ç¿ëÀÚº°(2020-2035³â)
    • º´¿ø ¹× Áø´Ü½ÇÇè½Ç
    • Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • CRO ¹× CMO
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ½ÃÀå ¿¹Ãø(±Ý¾× ±âÁØ) : : Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • ¹Ì±¹
  • ij³ª´Ù

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • µ¶ÀÏ
  • ¿µ±¹
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ½ºÀ§½º
  • ³×´ú¶õµå
  • ±âŸ À¯·´

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • Áß±¹
  • Àεµ
  • ÀϺ»
  • Çѱ¹
  • È£ÁÖ ¹× ´ºÁú·£µå
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • GCC ±¹°¡
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ - °æÀï ¸ÅÆ®¸¯½º(±â¾÷ Tierº°, ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® ±â¾÷º°(2024³â)
  • ±â¾÷ °³¿ä
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific
    • F. Hoffman-La Roche Ltd
    • Abbott
    • Siemens Healthineers
    • STEMCELL Technologies
    • Merck KGAA
    • Sysmex Corporation
    • Waters Corporation
    • Promega Corporation
    • Miltenyi Biotec
    • Beckman Coulter, Inc.
    • Bio-Techne
    • Biotium
LSH 25.08.19

Life Science Reagents Market- Scope of Report

TMR's report on the global Life Science Reagents Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Life Science Reagents Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Life Science Reagents Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 62.3 Bn
Market Value in 2035US$ 113.4 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Life Science Reagents Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Life Science Reagents Marketprofiled in this report.

Key Questions Answered in Global Life Science Reagents MarketReport:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Life Science Reagents Market- Research Objectives and Research Approach

The comprehensive report on the global Life Science Reagents Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Life Science Reagents Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Life Science Reagents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Life Science Reagents Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements associated with Life Science Reagents
  • 5.2. Regulatory Landscape across Key Regions / Countries
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTEL Analysis
  • 5.5. Key Product/Brand Analysis
  • 5.6. Key Industry Events
  • 5.7. Feature Analysis based on the Key Product Manufacturers
  • 5.8. Pricing Analysis
  • 5.9. Benchmarking of the Products Offered by the Competitors

6. Global Life Science Reagents Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020 to 2035
    • 6.3.1. Buffers and Solutions
    • 6.3.2. Chromatography Reagents
    • 6.3.3. Molecular Diagnostics Reagents
    • 6.3.4. Immunoassay Reagents
    • 6.3.5. Clinical Chemistry Reagents
    • 6.3.6. Flow Chemistry Reagents
    • 6.3.7. Cell and Tissue Culture Reagents
    • 6.3.8. Hematology and Hemostasis Reagents
    • 6.3.9. Microbiology Reagents
    • 6.3.10. Electrophoresis Reagents
    • 6.3.11. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Life Science Reagents Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Clinical Diagnostics
    • 7.3.2. Drug Discovery
    • 7.3.3. Genetic Engineering
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Application

8. Global Life Science Reagents Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 to 2035
    • 8.3.1. Hospitals and Diagnostic Laboratories
    • 8.3.2. Pharmaceutical & Biotechnology Companies
    • 8.3.3. CROs & CMOs
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Life Science Reagents Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Life Science Reagents Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020 to 2035
    • 10.2.1. Buffers and Solutions
    • 10.2.2. Chromatography Reagents
    • 10.2.3. Molecular Diagnostics Reagents
    • 10.2.4. Immunoassay Reagents
    • 10.2.5. Clinical Chemistry Reagents
    • 10.2.6. Flow Chemistry Reagents
    • 10.2.7. Cell and Tissue Culture Reagents
    • 10.2.8. Hematology and Hemostasis Reagents
    • 10.2.9. Microbiology Reagents
    • 10.2.10. Electrophoresis Reagents
    • 10.2.11. Others
  • 10.3. Market Value Forecast By Application, 2020 to 2035
    • 10.3.1. Clinical Diagnostics
    • 10.3.2. Drug Discovery
    • 10.3.3. Genetic Engineering
    • 10.3.4. Others
  • 10.4. Market Value Forecast By End-user, 2020 to 2035
    • 10.4.1. Hospitals and Diagnostic Laboratories
    • 10.4.2. Pharmaceutical & Biotechnology Companies
    • 10.4.3. CROs & CMOs
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Life Science Reagents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020 to 2035
    • 11.2.1. Buffers and Solutions
    • 11.2.2. Chromatography Reagents
    • 11.2.3. Molecular Diagnostics Reagents
    • 11.2.4. Immunoassay Reagents
    • 11.2.5. Clinical Chemistry Reagents
    • 11.2.6. Flow Chemistry Reagents
    • 11.2.7. Cell and Tissue Culture Reagents
    • 11.2.8. Hematology and Hemostasis Reagents
    • 11.2.9. Microbiology Reagents
    • 11.2.10. Electrophoresis Reagents
    • 11.2.11. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Clinical Diagnostics
    • 11.3.2. Drug Discovery
    • 11.3.3. Genetic Engineering
    • 11.3.4. Others
  • 11.4. Market Value Forecast By End-user, 2020 to 2035
    • 11.4.1. Hospitals and Diagnostic Laboratories
    • 11.4.2. Pharmaceutical & Biotechnology Companies
    • 11.4.3. CROs & CMOs
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Life Science Reagents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020 to 2035
    • 12.2.1. Buffers and Solutions
    • 12.2.2. Chromatography Reagents
    • 12.2.3. Molecular Diagnostics Reagents
    • 12.2.4. Immunoassay Reagents
    • 12.2.5. Clinical Chemistry Reagents
    • 12.2.6. Flow Chemistry Reagents
    • 12.2.7. Cell and Tissue Culture Reagents
    • 12.2.8. Hematology and Hemostasis Reagents
    • 12.2.9. Microbiology Reagents
    • 12.2.10. Electrophoresis Reagents
    • 12.2.11. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Clinical Diagnostics
    • 12.3.2. Drug Discovery
    • 12.3.3. Genetic Engineering
    • 12.3.4. Others
  • 12.4. Market Value Forecast By End-user, 2020 to 2035
    • 12.4.1. Hospitals and Diagnostic Laboratories
    • 12.4.2. Pharmaceutical & Biotechnology Companies
    • 12.4.3. CROs & CMOs
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Life Science Reagents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020 to 2035
    • 13.2.1. Buffers and Solutions
    • 13.2.2. Chromatography Reagents
    • 13.2.3. Molecular Diagnostics Reagents
    • 13.2.4. Immunoassay Reagents
    • 13.2.5. Clinical Chemistry Reagents
    • 13.2.6. Flow Chemistry Reagents
    • 13.2.7. Cell and Tissue Culture Reagents
    • 13.2.8. Hematology and Hemostasis Reagents
    • 13.2.9. Microbiology Reagents
    • 13.2.10. Electrophoresis Reagents
    • 13.2.11. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Clinical Diagnostics
    • 13.3.2. Drug Discovery
    • 13.3.3. Genetic Engineering
    • 13.3.4. Others
  • 13.4. Market Value Forecast By End-user, 2020 to 2035
    • 13.4.1. Hospitals and Diagnostic Laboratories
    • 13.4.2. Pharmaceutical & Biotechnology Companies
    • 13.4.3. CROs & CMOs
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Life Science Reagents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020 to 2035
    • 14.2.1. Buffers and Solutions
    • 14.2.2. Chromatography Reagents
    • 14.2.3. Molecular Diagnostics Reagents
    • 14.2.4. Immunoassay Reagents
    • 14.2.5. Clinical Chemistry Reagents
    • 14.2.6. Flow Chemistry Reagents
    • 14.2.7. Cell and Tissue Culture Reagents
    • 14.2.8. Hematology and Hemostasis Reagents
    • 14.2.9. Microbiology Reagents
    • 14.2.10. Electrophoresis Reagents
    • 14.2.11. Others
  • 14.3. Market Value Forecast By Application, 2020 to 2035
    • 14.3.1. Clinical Diagnostics
    • 14.3.2. Drug Discovery
    • 14.3.3. Genetic Engineering
    • 14.3.4. Others
  • 14.4. Market Value Forecast By End-user, 2020 to 2035
    • 14.4.1. Hospitals and Diagnostic Laboratories
    • 14.4.2. Pharmaceutical & Biotechnology Companies
    • 14.4.3. CROs & CMOs
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Becton, Dickinson and Company
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Agilent Technologies, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Thermo Fisher Scientific
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. F. Hoffman-La Roche Ltd
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Abbott
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Siemens Healthineers
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. STEMCELL Technologies
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Merck KGAA
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Sysmex Corporation
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Waters Corporation
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Promega Corporation
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Miltenyi Biotec
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Beckman Coulter, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Bio-Techne
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Financial Overview
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments
    • 15.3.16. Biotium
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Financial Overview
      • 15.3.16.3. Financial Overview
      • 15.3.16.4. Business Strategies
      • 15.3.16.5. Recent Developments
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦